Brilhante Raimunda Sâmia Nogueira, de Oliveira Jonathas Sales, de Jesus Evangelista Antonio José, Pereira Vandbergue Santos, Alencar Lucas Pereira, Castelo-Branco Débora de Souza Collares Maia, Câmara Lília Maria Carneiro, de Lima-Neto Reginaldo Gonçalves, Cordeiro Rossana de Aguiar, Sidrim José Júlio Costa, Rocha Marcos Fábio Gadelha
Department of Pathology and Legal Medicine, School of Medicine, Specialized Medical Mycology Center, Postgraduate Program in Medical Microbiology, Federal University of Ceará, Fortaleza-CE, Brazil.
Postgraduate Program in Medical Sciences, Federal University of Ceará, Fortaleza-CE, Brazil.
Med Mycol. 2018 Nov 1;56(8):1012-1022. doi: 10.1093/mmy/myx088.
The aim of this study was to evaluate the effect of promethazine on the antifungal minimum inhibitory concentrations against planktonic cells and mature biofilms of Candida tropicalis, as well as investigate its potential mechanisms of cell damage against this yeast species. Three C. tropicalis isolates (two azole-resistant and one azole-susceptible) were evaluated for their planktonic and biofilm susceptibility to promethazine alone and in combination with itraconazole, fluconazole, voriconazole, amphotericin B, and caspofungin. The antifungal activity of promethazine against C. tropicalis was investigated by performing time-kill curve assays and assessing rhodamine 6G efflux, cell size/granularity, membrane integrity, and mitochondrial transmembrane potential, through flow cytometry. Promethazine showed antifungal activity against planktonic cells and biofilms at concentrations of 64 and 128 μg/ml, respectively. The addition of two subinhibitory concentrations of promethazine reduced the antifungal MICs for all tested azole drugs against planktonic growth, reversing the resistance phenotype to all azoles. Promethazine decreased the efflux of rhodamine 6G in an azole-resistant strain. Moreover, promethazine decreased cell size/granularity and caused membrane damage, and mitochondrial membrane depolarization. In conclusion, promethazine presented synergy with azole antifungals against resistant C. tropicalis and exhibited in vitro cytotoxicity against C. tropicalis, altering cell size/granularity, membrane integrity, and mitochondrial function, demonstrating potential mechanisms of cell damage against this yeast species.
本研究旨在评估异丙嗪对热带念珠菌浮游细胞和成熟生物膜的抗真菌最低抑菌浓度的影响,并研究其对该酵母菌种细胞损伤的潜在机制。评估了三株热带念珠菌分离株(两株对唑类耐药,一株对唑类敏感)对单独使用异丙嗪以及与伊曲康唑、氟康唑、伏立康唑、两性霉素B和卡泊芬净联合使用时的浮游和生物膜敏感性。通过进行时间杀菌曲线测定,并通过流式细胞术评估罗丹明6G外排、细胞大小/粒度、膜完整性和线粒体跨膜电位,研究了异丙嗪对热带念珠菌的抗真菌活性。异丙嗪分别在64和128μg/ml的浓度下对浮游细胞和生物膜显示出抗真菌活性。添加两个亚抑菌浓度的异丙嗪降低了所有测试唑类药物对浮游生长的抗真菌最低抑菌浓度,逆转了对所有唑类的耐药表型。异丙嗪减少了唑类耐药菌株中罗丹明6G的外排。此外,异丙嗪减小了细胞大小/粒度并导致膜损伤以及线粒体膜去极化。总之,异丙嗪与唑类抗真菌药物对耐药热带念珠菌具有协同作用,并对热带念珠菌表现出体外细胞毒性,改变了细胞大小/粒度、膜完整性和线粒体功能,证明了对该酵母菌种细胞损伤的潜在机制。